Genotoxins cause significant damage to the genetic material of aquatic organisms, requiring rapid and accurate assessment. Fish derived cells sensitive to genotoxins have proven to be a useful tool for measuring genotoxicity, but the long treatment ti...
Genotoxins cause significant damage to the genetic material of aquatic organisms, requiring rapid and accurate assessment. Fish derived cells sensitive to genotoxins have proven to be a useful tool for measuring genotoxicity, but the long treatment times required for measurement limit their application in situations requiring rapid testing. Previous studies have shown that fish cells can be kept unstarved for up to 6 h using media containing 1% FBS. In this study, the 1% FBS/6 h parameter was used for genotoxicity assessment. Therefore, genotoxicity assessment was performed after only 6 h of genotoxin treatment in medium containing 1% FBS. The new genotoxicity assessment method provided faster and more accurate genotoxicity data for climbazole and metolachlor than the existing assessment system using the 15% FBS/96h parameter. Furthermore, these advantages in the new platform enabled the determination of genotoxicity of various genotoxins, such as dibenz[a,h]anthracene and ethoprophos. In summary, we have developed a genotoxicity assessment that can generate genotoxicity data rapidly and accurately. This new platform will serve as a foundation for rapid genotoxicity assessment of many genotoxins.
Damaged mitochondria generate high levels of reactive oxygen species (ROS), which worsen cellular senescence. Therefore, lowering ROS or removing damaged mitochondria is a promising strategy to relieve senescence. Using a small screen of natural products, we identified acteoside as a compound that clearly reduces intracellular ROS in senescent human dermal fibroblasts (HDFs). At 4 μM for 12 days, acteoside selectively induced apoptosis in senescent HDFs while reducing several senescence associated markers, including CDKN1A, RB1, MMP1, F2RL1 (PAR2), CXCL8, and IL1B. Acteoside also decreased lipofuscin and mitochondrial mass, consistent with the removal of damaged organelles, and increased basal oxygen consumption and ATP linked respiration, showing improved mitochondrial function. RNA-seq analysis showed strong induction of FOS; importantly, FOS overexpression alone reproduced reduced ROS, lower mitochondrial mass, higher respiration, and decreased CDKN1A expression, linking acteoside’s effects to an AP1-centered transcriptional program. Together, these findings suggest that acteoside is a senolytic candidate that improves mitochondrial quality and suppresses inflammatory signaling in vitro, supporting its potential as a natural lead compound for aging-related conditions.